Author:
Li Chunwei,Zhu Lili,Liu Qinghua,Peng Mengle,Deng Jinhai,Fan Zhirui,Duan Xiaoran,Xue Ruyue,Guo Zhiping,Lv Xuefeng,Li Lifeng,Zhao Jie
Reference51 articles.
1. Analysis of status and countermeasures of cancer incidence and mortality in China;Wu;Sci. China Life Sci.,2019
2. Cancer statistics, 2022;Siegel;CA A Cancer J. Clin.,2022
3. Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the global burden of disease study 2019;Global Burden of Disease Cancer;JAMA Oncol.,2022
4. Adjuvant and neoadjuvant cancer therapies: a historical review and a rational approach to understand outcomes;Burotto;Semin. Oncol.,2019
5. Neoadjuvant and adjuvant therapies for breast cancer;Apuri;South. Med. J.,2017